Filing Details
- Accession Number:
- 0001493152-23-011888
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-11 18:59:39
- Reporting Period:
- 2023-04-11
- Accepted Time:
- 2023-04-11 18:59:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 109657 | Gt Biopharma Inc. | GTBP | Pharmaceutical Preparations (2834) | 941620407 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1863633 | Martin Michael Breen | C/O Gt Biopharma, Inc. 8000 Marina Blvd., Ste. 100 Brisbane CA 94005 | Executive Chairman/Interim Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-11 | 50,000 | $0.50 | 656,218 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
